These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9284083)

  • 21. Metal contents of liver parenchyma after percutaneous ethanol injection or radiofrequency ablation in patients with hepatocellular carcinoma before and after trientine hydrochloride therapy.
    Fukuda H; Ebara M; Okabe S; Yoshikawa M; Sugiura N; Saisho H; Kondo F; Yukawa M
    J Lab Clin Med; 2004 Jun; 143(6):333-9. PubMed ID: 15192648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wilson disease in children: serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine) treatment.
    Arnon R; Calderon JF; Schilsky M; Emre S; Shneider BL
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):596-602. PubMed ID: 17460493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lights and shadows in the challenge of binding acyclovir, a synthetic purine-like nucleoside with antiviral activity, at an apical-distal coordination site in copper(II)-polyamine chelates.
    Pérez-Toro I; Domínguez-Martín A; Choquesillo-Lazarte D; Vílchez-Rodríguez E; González-Pérez JM; Castiñeiras A; Niclós-Gutiérrez J
    J Inorg Biochem; 2015 Jul; 148():84-92. PubMed ID: 25863571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copper chelating agents. A comparison of cupruretic responses to various tetramines and D-penicillamine.
    Borthwick TR; Benson GD; Schugar HJ
    J Lab Clin Med; 1980 Apr; 95(4):575-80. PubMed ID: 7359013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
    Dahlman T; Hartvig P; Löfholm M; Nordlinder H; Lööf L; Westermark K
    QJM; 1995 Sep; 88(9):609-16. PubMed ID: 7583074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of chelating agents on the excretion of copper, zinc and iron in the bile and urine of sheep.
    Gooneratne SR; Christensen DA
    Vet J; 1997 Mar; 153(2):171-8. PubMed ID: 12463402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired sideroblastic anaemia during treatment of Wilson's disease with triethylene tetramine dihydrochloride.
    Condamine L; Hermine O; Alvin P; Levine M; Rey C; Courtecuisse V
    Br J Haematol; 1993 Jan; 83(1):166-8. PubMed ID: 8435326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of cardiovascular autonomic dysfunction following anti-copper therapy in Wilson's disease.
    Deguchi K; Sasaki I; Touge T; Tsukaguchi M; Ikeda K; Shimamura M; Urai Y; Watanabe S; Takeuchi H; Kuriyama S
    J Neurol; 2005 Apr; 252(4):495-7. PubMed ID: 15726258
    [No Abstract]   [Full Text] [Related]  

  • 30. Trientine-induced neurological deterioration in a patient with Wilson's disease.
    Kim B; Chung SJ; Shin HW
    J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive atrophy of pancreatic acinar tissue in rats fed a copper-deficient diet supplemented with D-penicillamine or triethylene tetramine: morphological and physiological studies.
    Smith PA; Sunter JP; Case RM
    Digestion; 1982; 23(1):16-30. PubMed ID: 7084566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation induced by photocoagulation laser is minimized by copper chelators.
    Cui JZ; Wang XF; Hsu L; Matsubara JA
    Lasers Med Sci; 2009 Jul; 24(4):653-7. PubMed ID: 18566852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Urinary copper excretion from rats following administration of aliphatic and alicyclic polyamines (author's transl)].
    Harders H; Armah B; Cohnen E; Führ J; Heinz N; Schröder HF
    Arzneimittelforschung; 1980; 30(2):254-8. PubMed ID: 7378100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copper chelation by trientine dihydrochloride inhibits liver RFA-induced inflammatory responses in vivo.
    Yin JM; Sun LB; Zheng JS; Wang XX; Chen DX; Li N
    Inflamm Res; 2016 Dec; 65(12):1009-1020. PubMed ID: 27613237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cadmium mobilization by nitrogen donor chelating agents.
    Jones MM; Xu C; Singh PK; Walker EM
    J Toxicol Environ Health; 1996 May; 48(1):71-80. PubMed ID: 8637059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined effects of steroids, ethanol and protein deficiency on tissue content and urinary and faecal excretion of zinc, copper and iron.
    González-Reimers E; Santolaria-Fernández F; Garrido-Benedicto P; Durán-Castellón MC; Galindo-Martín L; Martínez-Riera A; Viña-Rodríguez J; de la Vega-Prieto MJ
    Alcohol Alcohol; 2002; 37(2):132-7. PubMed ID: 11912068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites.
    Nurchi VM; Crisponi G; Crespo-Alonso M; Lachowicz JI; Szewczuk Z; Cooper GJ
    Dalton Trans; 2013 May; 42(17):6161-70. PubMed ID: 23202417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study of trientine therapy in Wilson's disease with neurological symptoms].
    Suda M; Kubota J; Yamaguchi Y; Fujioka Y; Saito Y; Aoki T
    No To Hattatsu; 1993 Sep; 25(5):429-34. PubMed ID: 8398232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wilson's disease.
    Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
    Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.